AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 9 Sponsors

Apr 9, 2026 · Senate

RPTD. OUT OF LCO

Apr 9, 2026 · Senate

FAV. RPT., TAB. FOR CAL., SEN.

Apr 9, 2026 · Senate

SENATE CALENDAR NUMBER 332

Apr 9, 2026 · Senate

FILE NO. 566

Apr 2, 2026 · Senate

REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/08/26

Mar 24, 2026 · Senate

FILED WITH LCO

Mar 23, 2026 · Senate

Joint Favorable

Mar 9, 2026 · Senate

PUBLIC HEARING 0313

Mar 5, 2026 · Senate

REF. TO JOINT COMM. ON Public Health

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Floor Consideration — base rate 20%, measured from CT's completed sessions
Momentum -2 42/100 from the pace of recorded action
Time since last action -22 185 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.